Pain Medicine, Interventional Pain Medicine · Darby, PA
NPI
1184074783
Since 2016
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
1500 Lansdowne Ave
Darby, PA, 19023
Phone (610) 237-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$409K
10,234 services
Medicare patients, 2024
409
Average age 73
Drug cost, 2024
$156K
3,608 prescriptions
Company payments, 2025
$1,607
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chad J Metzger was code J3301 (injection, triamcinolone acetonide, not otherwise specified, 10 mg), 1,515 times for 142 patients. In total Chad J Metzger billed 10,234 services in 54 codes, and Medicare paid $409K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-15.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,515 | 142 | $0.78 | $1,181 |
| 99214 Office E&M - Established | Office | 1,427 | 336 | $100.00 | $143K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,020 | 49 | $0.09 | $91.78 |
| 96127 Behavioral Health Services | Office | 767 | 255 | $3.67 | $2,816 |
| 80307 Drug Tests | Office | 308 | 106 | $60.90 | $19K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 188 | 53 | $49.71 | $9,346 |
| 99204 Office E&M - New | Office | 179 | 179 | $128.88 | $23K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 126 | 49 | $241.98 | $30K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 115 | 52 | $153.46 | $18K |
| Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 101 | 84 | $0.28 | $28.75 |
| 62323 Nerve Block Injection - Back | Office | 91 | 67 | $210.58 | $19K |
| 64493 Nerve Block Injection - Back | Office | 72 | 42 | $216.31 | $16K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 68 | 37 | $112.14 | $7,626 |
| 64494 Nerve Block Injection - Back | Office | 67 | 39 | $110.59 | $7,410 |
| 64636 Destruction by Neurolytic Agent - Back | Office | 66 | 28 | $196.95 | $13K |
By year: 2022 $282K for 4,389 services; 2023 $493K for 10,931 services; 2024 $409K for 10,234 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 308 | 106 | $60.90 | $19K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 126 | 49 | $241.98 | $30K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 115 | 52 | $153.46 | $18K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 68 | 37 | $112.14 | $7,626 |
Medicare prescription drug claims, 2024
In 2024, the drug Chad J Metzger prescribed most often to Medicare patients was Oxycodone Hcl, with 558 prescriptions and refills. In total Chad J Metzger wrote 3,608 Medicare prescriptions that cost $156K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 558 | 558 | 68 | $11K |
| Gabapentin Generic | 509 | 554 | 125 | $4,590 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 492 | 492 | 62 | $12K |
| Tramadol Hcl Generic | 248 | 248 | 57 | $2,186 |
| Tizanidine Hcl Generic | 248 | 284 | 76 | $2,282 |
| Pregabalin Generic | 237 | 269 | 47 | $2,539 |
| Morphine Sulfate Er Morphine Sulfate | 211 | 211 | 24 | $9,300 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 174 | 174 | 33 | $2,519 |
| Meloxicam Generic | 159 | 179 | 41 | $523 |
| Celecoxib Generic | 80 | 99 | 20 | $605 |
| Duloxetine Hcl Generic | 57 | 63 | Under 11 | $597 |
| Diclofenac Sodium Generic | 39 | 49 | 12 | $340 |
| Endocet Oxycodone Hcl/Acetaminophen | 37 | 37 | Under 11 | $2,975 |
| Lidocaine Generic | 36 | 36 | 14 | $2,300 |
| Hydromorphone Hcl Generic | 35 | 35 | Under 11 | $485 |
Brand drugs: 155 claims; generic drugs: 3,453 claims; opioid claims: 1,898.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chad J Metzger $1,607 ($1,607 in general payments such as food, travel and fees) from 14 companies. The largest payer was Boston Scientific Corporation with $580.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 28 | $580 |
| Abbott Laboratories ABT | 15 | $333 |
| Stryker Corporation SYK | 2 | $168 |
| Foundation Fusion Solutions, LLC | 5 | $98.71 |
| Globus Medical, Inc. GMED | 3 | $91.14 |
| Vertex Pharmaceuticals Incorporated VRTX | 3 | $80.85 |
| Collegium Pharmaceutical, Inc. COLL | 3 | $58.39 |
| IBSA Pharma Inc. | 2 | $47.14 |
| Spinal Simplicity, LLC | 1 | $44.88 |
| Pfizer Inc. PFE | 1 | $26.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.